Skip to main content
. 2023 Nov 4;14(3):1009–1029. doi: 10.1016/j.apsb.2023.10.023

Table 1.

Summary of histone modification in liver fibrosis.

Histone modification Consequence Target Cell type/animal model
Methylation Inhibits transcription
H3K27me3 TGF-β/IGFBP3 HSC
H3K9me2/3 TLR4/NF-κB/PPARγ HSC
H4K20me3 Bax HSC
Methylation Promotes transcription
H3K4me1/3 NLRP3/Bivalent domains in PPARγ Hepatocyte/HSC
H3K36me3 Bivalent domains with H3K27me3 HSC
H3K79me3 Cul4 with Clr4 Hepatocyte
Acetylation Promotes transcription
H3K27ac CCL2 LSEC
H3K9ac Fibronectin and Serpine1 Cholangiocytes